Navigation Links
University of Maryland Medical Center launches genetic-testing program for cardiac patients
Date:5/14/2013

BALTIMORE May 14, 2013. Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center now can receive long-term therapy based on information found in their genes. As part of a new personalized medicine initiative, the medical center is offering genetic testing to help doctors determine which medication a patient should take after a stenting procedure in order to prevent blood clots that could lead to serious and potentially fatal heart attacks and strokes.

Patients with suspected heart disease undergo coronary catheterization to identify blocked or narrow arteries. Tiny tubes, or stents, are often placed in the arteries to keep them open, and, after surgery, patients typically take antiplatelet drugs, such as clopidogrel (Plavix), to prevent platelets blood cells produced in bone marrow from sticking together and forming clots.

Now, patients who undergo coronary catheterization at UMMC and the Baltimore VA Medical Center, both of which are affiliated with the University of Maryland School of Medicine, can elect to be tested for variations in a gene called CYP2C19. Up to one-fourth of the U.S. population carries at least one abnormal copy of the CYP2C19 gene, and research has shown that as a result, these individuals do not metabolize the standard anti-clotting medication clopidogrel effectively.

"There is strong clinical data to support pharmacogenetic testing in regard to antiplatelet therapy," says Alan R. Shuldiner, M.D., the John L. Whitehurst Endowed Professor of Medicine, associate dean for personalized medicine and director of the Program in Personalized and Genomic Medicine at the University of Maryland School of Medicine. "It's time to incorporate genetics into the complex medical decisions that we make on behalf of our patients."

In 2009, Dr. Shuldiner led a University of Maryland study, published in JAMA, which showed that patients with a CYP2C19 gene variati
'/>"/>

Contact: Karen Warmkessel
kwarmkessel@umm.edu
41-032-889-194-104-041-53
University of Maryland Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. University of Maryland School of Medicine researchers find potential novel treatment for influenza
2. University of Houston engineering professor awarded grant to study melanoma treatment
3. Saint Louis University, University of Toronto biologists help decode turtle genome
4. Wayne State University startup, Advaita, to participate in new Michigan I-Corps program
5. Indiana University associate professor earns APSs Henry Pickering Bowditch Award
6. University of Southern California scientists reveal natural process that blocks viruses
7. University of Houston engineering researchers theories to be tested in space
8. University of Tennessee professors research shows Gulf of Mexico resilient after spill
9. Mercyhurst Universitys new DNA sequencer to accelerate scientific research in region
10. Student named universitys first Lawrence scholar, researching at national laboratory
11. University of Tennessee professor links massive prehistoric bird extinction to human colonization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2015)...   MedNet Solutions , a global life ... systems, has recently bolstered its iMedNet™ ... iMedNet as the eClinical solution of ... consultants.  Building on the Program,s existing benefits (including ... co-marketing opportunities), MedNet,s new and improved program provides ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America recently ... for carbon nanotube (CNT) macrostructures, including sheets, yarns and ... (UTD). Leveraging the vast industrial resources of ... Japan , Lintec of America is forming the ... TX , focusing on scaling up the manufacturing ...
(Date:2/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces the ... as part of its 2015 marketing and branding initiatives ... new consumer website for Wocketwallet.com earlier this month. ... said, "Our new corporate website naturally showcases our premiere ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... of Vanderbilt scientists have invented the world,s smallest version of ... and other micro-organisms from several sides at once. "With ... side, the top," says team member Chris Janetopoulos, assistant professor ... of cells, we can view their sides as well ...
... with a crab,s pinchers, consider that the claw tips ... than acrylic glass and extremely fracture resistant, says a ... West Coast may have had close encounters with the ... paper published online in advance of regular publication in ...
... and University of Guam research scientist Dr. Gadi V. P. ... methods to control invasive plants. A chemical ecologist and entomologist, ... Biological Control of Tropical Weeds using Arthropods , which ... available to the public in March 2009. Dr. Reddy coauthored ...
Cached Biology News:Vanderbilt scientists invent world's smallest periscopes 2Vanderbilt scientists invent world's smallest periscopes 3Crab claws pack strengthening bromide-rich biomaterial 2
(Date:3/5/2015)... Bi-Biomics today announced a discovery made ... The improvement in histological quality provided the detail ... all daughter cells. , After processing with Ultralight ... at 1000-1600x using light microscopy. Phylogenetic and ... daughter cells displayed predominant binary features --- one ...
(Date:3/5/2015)... SAN DIEGO , March 5, 2015  In ... Marketwired in Miami, FL on ... company are both of strong financial health and their ... as clinical research has indicated. Furthermore, Impeto prefers to have ... There are more than 40 articles written ...
(Date:3/4/2015)... In an article published and posted online today, senior ... the clinical aspects of diseases caused by 5 major ... "Clinical Management of Potential Bioterrorism-Related Conditions," was published and ... New England Journal of Medicine . ... Inglesby—review the clinical management of conditions resulting from exposure ...
(Date:3/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/jspg2c/global_biologics ... "Global Biologics and Biosimilars Industry Report 2015" ... The Global Biologics and Biosimilars Industry Report 2015 ... current state of the biologics and biosimilars industry. ... of the industry including definitions, classifications, applications and ...
Breaking Biology Technology:Impeto Medical Responds to Published Allegations by LD Technology LLC ("LD") 2Latest Clinical Information On Bioterrorism Threats 2Global Biologics and Biosimilars Industry Report 2015-2020 2
... Richard P. Jones II named Vice President and General Manager ... dispense up to one million prescriptions a week, FRANKLIN ... MHS ), one of the nation,s leading pharmacy benefit,managers, today ... home of world,s largest and most-advanced automated pharmacy,capping a nearly ...
... SYK ) announced that it will host a ... Eastern Time, to discuss the Company,s,operating results for the ... operational update. Operating results for the quarter and year,ended ... that day., Stephen P. MacMillan, President and Chief ...
... of over 100 RNA-related Inventions a Key Step in Establishing ... MDRNA ... Nastech,Pharmaceutical Company Inc. ("Nastech") (Nasdaq: NSTK ) announced today ... and (ii) Nastech,s own intellectual property, as such intellectual,property relates ...
Cached Biology Technology:Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 2Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 3Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 4Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 5Stryker to Host Conference Call on January 23, 2008 2Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc. 2Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc. 3Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc. 4Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc. 5
PxE thermal Cycler. 0.5ml block holds 48 0.5 ml tubes or 96 0.3 ml tubes. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User frien...
For testing the AQUA technique on your MS instruments....
0.2ml Gradient Block MBSR. Robot compatible block ejection mechanism. Stackable. (96 well block - holds 1 plate 0.2ml x 96 well plate)...
Our original highly-purified, robust Taq Polymerase which delivers consistently high yields and minimal background...
Biology Products: